Genome-wide identification and oxacillinase OXA distribution characteristics of Acinetobacter spp. based on a global database [PDF]
Frontiers in Microbiology, 2023 ObjectiveTo use genomic analysis to identify Acinetobacter spp. and to explore the distribution characteristics of ß-lactamase oxallicinases (blaOXA) among Acinetobacter species globally.MethodsGenomes of global Acinetobacter spp.
Jia Li +8 more
doaj +3 more sources
In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations [PDF]
Microbiology SpectrumCarbapenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. represent major threats and have few approved therapeutic options. Non-fermenting Gram-negative isolates were collected from hospitalized inpatients from 49 sites in 6 European countries
Anne Santerre Henriksen +7 more
doaj +3 more sources
Pathogens, 2021 Acinetobacter spp., the nosocomial pathogen, forms strong biofilms and is resistant to numerous antibiotics, causing persistent infections. This study investigates the antibacterial and anti-biofilm activity of polymyxin E alone and in combination with ...
Munaf AL-Dulaimi +6 more
doaj +2 more sources
Update on Multidrug Resistance Efflux Pumps in Acinetobacter spp. [PDF]
Antimicrob Agents Chemother, 2021 Acinetobacter spp. have become of increased clinical importance as studies have shown the antimicrobial resistant potential of these species. Efflux pumps can lead to reduced susceptibility to a variety of antibiotics and are present in large number ...
Kornelsen V, Kumar A.
europepmc +2 more sources
Treatment effectiveness of antibiotic therapy in Veterans with multidrug-resistant Acinetobacter spp. bacteremia [PDF]
Antimicrobial Stewardship & Healthcare Epidemiology, 2023 Objective: To describe antimicrobial therapy used for multidrug-resistant (MDR) Acinetobacter spp. bacteremia in Veterans and impacts on mortality. Methods: This was a retrospective cohort study of hospitalized Veterans Affairs patients from 2012 to ...
Amanda Vivo +6 more
doaj +2 more sources
Molecular epidemiology and antimicrobial susceptibility of Pseudomonas spp. and Acinetobacter spp. from clinical samples at Jimma medical center, Ethiopia. [PDF]
Front Microbiol, 2022 Introduction Pseudomonas aeruginosa (P. aeruginosa) and Acinetobacter baumannii (A. baumannii) can cause difficult-to-treat infections. We characterized molecular epidemiology of ceftazidime-resistant P. aeruginosa and carbapenem-resistant A.
Sewunet T +4 more
europepmc +2 more sources
Antimicrobial Resistance in Acinetobacter spp. and Pseudomonas spp
Microbiology Spectrum, 2018 The nonfermenting bacteria belonging to Acinetobacter spp. and Pseudomonas spp. are capable of colonizing both humans and animals and can also be opportunistic pathogens.
Agnese Lupo, M. Haenni, J. Madec
semanticscholar +3 more sources
Co-occurrence of Plasmid-Mediated Tigecycline and Carbapenem Resistance in Acinetobacter spp. from Waterfowls and Their Neighboring Environment. [PDF]
Antimicrob Agents Chemother, 2020 Tigecycline serves as one of the antibiotics of last resort to treat multidrug-resistant (including carbapenem-resistant) pathogens. However, the recently emerged plasmid-mediated tigecycline resistance mechanism, Tet(X), challenges the clinical efficacy
Cui CY +15 more
europepmc +2 more sources
PLoS Genetics, 2017 The emergence and spread of antibiotic resistance among Acinetobacter spp. have been investigated extensively. Most studies focused on the multiple antibiotic resistance genes located on plasmids or genomic resistance islands.
Gang Zhang +7 more
doaj +2 more sources
Annals of Clinical Microbiology and Antimicrobials, 2017 Introduction Pseudomonas aeruginosa and Acinetobacter spp. are found to be associated with biofilm and metallo-β-lactamase production and are the common causes of serious infections mainly in hospitalized patients. So, the main aims of this study were to
Bandana Baniya +8 more
doaj +2 more sources